Cantel Medical (CMD) Reports In-Line Q1 EPS

Cantel Medical (NYSE: CMD) reported Q1 EPS of $0.62, in-line with the analyst estimate of $0.62. Revenue for the quarter came in at $225.6 million versus the consensus estimate of $228.16 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• China semiconductor equipment imports grow 9% in July, Barclays comments
• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance